- News Home
10 April 2014 11:44 am ,
Vol. 344 ,
Tight budgets are forcing NASA to consider turning off one or more planetary science projects that have completed their...
Ebola is not a stranger to West Africa—an outbreak in the 1990s killed chimpanzees and sickened one researcher. But the...
In an as-yet-unpublished report, an international panel of geoscientists has concluded that a pair of deadly...
Tropical disease experts tried and failed before to eradicate yaws, a rare disfiguring disease of poor countries. Now,...
Since 2002, researchers have reported that agricultural communities in the hot and humid Pacific Coast of Central...
Balkan endemic kidney disease surfaced in the 1950s and for decades defied attempts to finger the cause. It occurred...
The Pyrenean ibex, an impressive mountain goat that lived in the central Pyrenees in Spain, went extinct in 2000. But a...
- 10 April 2014 11:44 am , Vol. 344 , #6180
- About Us
Only 1.4% Boost for NIH From Senate Panel
29 July 2009 11:39 am
A Senate spending panel has matched President Barack Obama's request for funding for the National Institutes of Health in 2010—a $442 million boost to $31.8 billion. That slight 1.4% bump is less than half of the increase the House of Representatives approved last week. After the full committee and Senate approve the bill, it will be reconciled with the House version.
Like the president, the Senate appropriations labor, health and human services subcommittee, headed by Tom Harkin (D–IA), felt that NIH didn't need more money because the Recovery Act gave it $10 billion to spend through 2010. The bill "was greatly influenced" by the funding in the Act, a statement from the committee says. But the bill does not include the president's request for bigger boosts for cancer and autism research, according to Jennifer Zeitzer, director of legislative relations for the Federation of American Societies for Experimental Biology. FASEB is "pleased" because disease-specific allocations go against the serendipitous nature of scientific discovery, she says. FASEB is hoping for a higher overall number for NIH in the conference with the House.